HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jae-Chun Ryu Selected Research

benzo(k)fluoranthene

11/2013Polycyclic aromatic hydrocarbon (PAH)-mediated upregulation of hepatic microRNA-181 family promotes cancer cell migration by targeting MAPK phosphatase-5, regulating the activation of p38 MAPK.
7/2012Identification of molecular signatures predicting the carcinogenicity of polycyclic aromatic hydrocarbons (PAHs).
9/2011Polycyclic aromatic hydrocarbons induce migration in human hepatocellular carcinoma cells (HepG2) through reactive oxygen species-mediated p38 MAPK signal transduction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jae-Chun Ryu Research Topics

Disease

5Neoplasms (Cancer)
06/2017 - 02/2009
4Leukemia
06/2017 - 05/2010
3Inflammation (Inflammations)
10/2017 - 02/2009
3Hepatocellular Carcinoma (Hepatoma)
11/2013 - 09/2011
2Respiratory Tract Diseases (Respiratory Tract Disease)
11/2018 - 06/2017
2Lung Diseases (Lung Disease)
10/2017 - 12/2016
2Chronic Obstructive Pulmonary Disease (COPD)
10/2017 - 12/2016
2Rheumatoid Arthritis
07/2009 - 02/2009
1Fibrosis (Cirrhosis)
10/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2017
1Nervous System Diseases (Neurological Disorders)
06/2017
1Cardiovascular Diseases (Cardiovascular Disease)
06/2017
1Thyroid Dyshormonogenesis 4
06/2013
1Polyps
06/2012
1Follicular Adenocarcinoma
09/2011
1Aplastic Anemia (Anemia, Hypoplastic)
09/2011
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2011
1Lymphoma (Lymphomas)
09/2011
1Pneumonia (Pneumonitis)
02/2009
1Neuroblastoma
05/2007
1Cataract (Cataracts)
08/2003
1Carcinogenesis
07/2002

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
10/2017 - 05/2010
3benz(a)anthracene (benzanthracene)IBA
11/2013 - 09/2011
3p38 Mitogen-Activated Protein KinasesIBA
11/2013 - 02/2009
3benzo(k)fluorantheneIBA
11/2013 - 09/2011
2Particulate MatterIBA
11/2018 - 05/2017
2n-hexanal (hexanal)IBA
10/2017 - 12/2016
2TolueneIBA
06/2017 - 02/2011
2MicroRNAs (MicroRNA)IBA
06/2017 - 11/2013
2Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
11/2013 - 09/2011
2pyreneIBA
07/2012 - 09/2011
2OligonucleotidesIBA
09/2011 - 05/2010
2Benzene (Benzole)IBA
09/2011 - 02/2011
2Reactive Oxygen Species (Oxygen Radicals)IBA
09/2011 - 02/2011
2Methotrexate (Mexate)FDA LinkGeneric
07/2009 - 02/2009
1AldehydesIBA
10/2017
1CytokinesIBA
10/2017
1ErbB Receptors (EGF Receptor)IBA
05/2017
1CarcinogensIBA
11/2013
1Thyroid HormonesIBA
06/2013
1chryseneIBA
07/2012
1MethylcholanthreneIBA
07/2012
11,2,5,6-dibenzanthracene (dibenz(a,h)anthracene)IBA
07/2012
1phenanthreneIBA
07/2012
1naphthaleneIBA
07/2012
1Benzo(a)pyreneIBA
07/2012
1ToxapheneIBA
06/2012
1AntioxidantsIBA
06/2012
1EnzymesIBA
06/2012
1Proteins (Proteins, Gene)FDA Link
06/2012
1RNA (Ribonucleic Acid)IBA
06/2012
1Environmental Pollutants (Pollutants, Environmental)IBA
09/2011
12-xylene (o-xylene)IBA
02/2011
1Volatile Organic CompoundsIBA
05/2010
1Interleukin-8 (Interleukin 8)IBA
02/2009
1Tretinoin (Retinoic Acid)FDA LinkGeneric
05/2007
1Aldehyde Reductase (Aldose Reductase)IBA
08/2003
19- (2,3- dihydroxy- 3- methylbutoxy)- 4- methoxy- 7H- furo(3,2- g)(1)benzopyran- 7- oneIBA
08/2003
1BenzopyransIBA
08/2003
11,2-dibromo-3-chloropropane (DBCP)IBA
07/2002